Feasibility of everolimus-eluting bioresorbable vascular scaffolds in patients with chronic total occlusion

International Journal of Cardiology

Volumn 179, Issue , 2015, Pages 90-94

  Wiebe, Jens ^a   Liebetrau, Christoph ^a,b   Dörr, Oliver ^a   Most, Astrid ^a   Weipert, Kay ^a   Rixe, Johannes ^a   Bauer, Timm ^a   Möllmann, Helge ^b   Elsässer, Albrecht ^c   Hamm, Christian W ^a,b   Nef, Holger M ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b Kerckhoff Heart and Thorax Center   (Germany)

^c KLINIKUM OLDENBURG   (Germany)

Author keywords

Biodegradable; Bioresorbable vascular scaffold; Chronic total coronary occlusion; Coronary artery disease; Percutaneous coronary intervention; Stent

Indexed keywords

ACETYLSALICYLIC ACID PLUS CLOPIDOGREL; ANTITHROMBOCYTIC AGENT; EVEROLIMUS; PRASUGREL; TICAGRELOR; IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ANGIOGRAPHY; ARTICLE; BIORESORBABLE VASCULAR STENT; CHRONIC TOTAL OCCLUSION; CLINICAL ARTICLE; CONTRAST VOLUME; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OCCLUSION; DIABETES MELLITUS; DRUG ELUTING STENT; FEASIBILITY STUDY; FEMALE; FLUOROSCOPY; FOLLOW UP; GUIDE WIRE; HEART DISEASE; HOSPITALIZATION; HUMAN; HYPERTENSION; IMPLANTATION; IN SCAFFOLD THROMBOSIS; J SCORE; MALE; OPERATION DURATION; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; RATING SCALE; RECANALIZATION; SURGICAL WIRE; THROMBOSIS; TREATMENT DURATION; WEIGHT, MASS AND SIZE; ANALOGS AND DERIVATIVES; BIODEGRADABLE IMPLANT; COMORBIDITY; CORONARY OCCLUSION; MIDDLE AGED; RISK FACTOR; TISSUE SCAFFOLD; TREATMENT OUTCOME;

ABSORBABLE IMPLANTS; COMORBIDITY; CORONARY OCCLUSION; DRUG-ELUTING STENTS; FEASIBILITY STUDIES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; RISK FACTORS; SIROLIMUS; TISSUE SCAFFOLDS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME;

EID: 84920647155     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.10.032     Document Type: Article

References (28)

1. Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), European Association for Percutaneous Cardiovascular Interventions (EAPCI), W. Wijns, P. Kolh, N. Danchin, C. Di Mario, V. Falk, T. Folliguet, S. Garg, K. Huber, S. James, J. Knuuti, J. Lopez-Sendon, J. Marco, L. Menicanti, M. Ostojic, M.F. Piepoli, C. Pirlet, J.L. Pomar, N. Reifart, F.L. Ribichini, M.J. Schalij, P. Sergeant, P.W. Serruys, S. Silber, M. Sousa Uva, and D. Taggart Guidelines on myocardial revascularization Eur. Heart J. 31 2010 2501 2555
2. G.N. Levine, E.R. Bates, J.C. Blankenship, S.R. Bailey, J.A. Bittl, B. Cercek, C.E. Chambers, S.G. Ellis, R.A. Guyton, S.M. Hollenberg, U.N. Khot, R.A. Lange, L. Mauri, R. Mehran, I.D. Moussa, D. Mukherjee, B.K. Nallamothu, H.H. Ting, American College of Cardiology Foundation, American Heart Association Task Force on Practice Guidelines, and Society for Cardiovascular Angiography and Interventions 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions J. Am. Coll. Cardiol. 58 2011 e44 e122
3. V.G. Patel, K.M. Brayton, A. Tamayo, O. Mogabgab, T.T. Michael, N. Lo, M. Alomar, D. Shorrock, D. Cipher, S. Abdullah, S. Banerjee, and E.S. Brilakis Angiographic success and procedural complications in patients undergoing percutaneous coronary chronic total occlusion interventions: a weighted meta-analysis of 18,061 patients from 65 studies JACC Cardiovasc. Interv. 6 2013 128 136
4. G. Niccoli, A. Leo, S. Giubilato, N. Cosentino, A.R. Galassi, S. Minelli, I. Porto, A.M. Leone, F. Burzotta, C. Trani, and F. Crea A meta-analysis of first-generation drug-eluting vs bare-metal stents for coronary chronic total occlusion: effect of length of follow-up on clinical outcome Int. J. Cardiol. 150 2011 351 354
5. G. Nakazawa, F. Otsuka, M. Nakano, M. Vorpahl, S.K. Yazdani, E. Ladich, F.D. Kolodgie, A.V. Finn, and R. Virmani The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents J. Am. Coll. Cardiol. 57 2011 1314 1322
6. A.V. Finn, M. Joner, G. Nakazawa, F. Kolodgie, J. Newell, M.C. John, H.K. Gold, and R. Virmani Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization Circulation 115 2007 2435 2441
7. M. Joner, A.V. Finn, A. Farb, E.K. Mont, F.D. Kolodgie, E. Ladich, R. Kutys, K. Skorija, H.K. Gold, and R. Virmani Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk J. Am. Coll. Cardiol. 48 2006 193 202
8. Y. Onuma, P.W. Serruys, L.E. Perkins, T. Okamura, N. Gonzalo, H.M. García-García, E. Regar, M. Kamberi, J.C. Powers, R. Rapoza, H. van Beusekom, W. van der Giessen, and R. Virmani Intracoronary optical coherence tomography and histology at 1 month and 2, 3, and 4 years after implantation of everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: an attempt to decipher the human optical coherence tomography images in the ABSORB trial Circulation 122 2010 2288 2300
9. P.W. Serruys, Y. Onuma, D. Dudek, P.C. Smits, J. Koolen, B. Chevalier, B. de Bruyne, L. Thuesen, D. McClean, R.J. van Geuns, S. Windecker, R. Whitbourn, I. Meredith, C. Dorange, S. Veldhof, K.M. Hebert, K. Sudhir, H.M. Garcia-Garcia, and J.A. Ormiston Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes J. Am. Coll. Cardiol. 58 2011 1578 1588
10. N. Patel, and A.P. Banning Bioabsorbable scaffolds for the treatment of obstructive coronary artery disease: the next revolution in coronary intervention? Heart 99 2013 1236 1243
11. J.A. Ormiston, P.W. Serruys, Y. Onuma, R.J. van Geuns, B. de Bruyne, D. Dudek, L. Thuesen, P.C. Smits, B. Chevalier, D. McClean, J. Koolen, S. Windecker, R. Whitbourn, I. Meredith, C. Dorange, S. Veldhof, K.M. Hebert, R. Rapoza, and H.M. Garcia-Garcia First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study Circ. Cardiovasc. Interv. 5 2012 620 632
12. G.W. Stone, D.E. Kandzari, R. Mehran, A. Colombo, R.S. Schwartz, S. Bailey, I. Moussa, P.S. Teirstein, G. Dangas, D.S. Baim, M. Selmon, B.H. Strauss, H. Tamai, T. Suzuki, K. Mitsudo, O. Katoh, D.A. Cox, A. Hoye, G.S. Mintz, E. Grube, L.A. Cannon, N.J. Reifart, M. Reisman, A. Abizaid, J.W. Moses, M.B. Leon, and P.W. Serruys Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part I Circulation 112 2005 2364 2372
13. Y. Morino, M. Abe, T. Morimoto, T. Kimura, Y. Hayashi, T. Muramatsu, M. Ochiai, Y. Noguchi, K. Kato, Y. Shibata, Y. Hiasa, O. Doi, T. Yamashita, T. Hinohara, H. Tanaka, K. Mitsudo, and J.-C.T.O. Registry Investigators Predicting successful guidewire crossing through chronic total occlusion of native coronary lesions within 30 minutes: the J-CTO (Multicenter CTO Registry in Japan) score as a difficulty grading and time assessment tool JACC Cardiovasc. Interv. 4 2011 213 221
14. S.B. Pancholy, P. Boruah, I. Ahmed, T. Kwan, T.M. Patel, and S. Saito Meta-analysis of effect on mortality of percutaneous recanalization of coronary chronic total occlusions using a stent-based strategy Am. J. Cardiol. 111 2013 521 525
15. D.A. Jones, R. Weerackody, K. Rathod, J. Behar, S. Gallagher, C.J. Knight, A. Kapur, A.K. Jain, M.T. Rothman, C.A. Thompson, A. Mathur, A. Wragg, and E.J. Smith Successful recanalization of chronic total occlusions is associated with improved long-term survival JACC Cardiovasc. Interv. 5 2012 380 388
16. E.L. Hannan, M. Racz, D.R. Holmes, S.B. King III, G. Walford, J.A. Ambrose, S. Sharma, S. Katz, L.T. Clark, and R.H. Jones Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era Circulation 113 2006 2406 2412
17. J.A. Grantham, P.G. Jones, L. Cannon, and J.A. Spertus Quantifying the early health status benefits of successful chronic total occlusion recanalization: results from the FlowCardia's Approach to Chronic Total Occlusion Recanalization (FACTOR) Trial Circ. Cardiovasc. Qual. Outcomes 3 2010 284 290
18. D. Joyal, J. Afilalo, and S. Rinfret Effectiveness of recanalization of chronic total occlusions: a systematic review and meta-analysis Am. Heart J. 160 2010 179 187
19. C.W. Lee, K.H. Park, Y.H. Kim, M.K. Hong, J.J. Kim, S.W. Park, and S.J. Park Clinical and angiographic outcomes after placement of multiple overlapping drug-eluting stents in diffuse coronary lesions Am. J. Cardiol. 98 2006 918 922
20. J. Aoki, A.T. Ong, G.A. Rodriguez Granillo, E.P. McFadden, C.A. van Mieghem, M. Valgimigli, K. Tsuchida, G. Sianos, E. Regar, P.P. de Jaegere, W.J. van der Giessen, P.J. de Feyter, R.T. van Domburg, and P.W. Serruys "Full metal jacket" (stented length > or = 64 mm) using drug-eluting stents for de novo coronary artery lesions Am. Heart J. 150 2005 994 999
21. O. Dörr, C. Liebetrau, F. Hecker, J. Wiebe, H. Möllmann, C. Hamm, and H. Nef "Full bioresorbable jacket": a new era has begun Herz 2013 10.1007/s00059-013-3912-1
22. J. Cockburn, E. Shaw, R. Bhindi, and P. Hansen Treatment of a left anterior descending artery chronic total occlusion using a bio-absorbable scaffold, utilising optical coherence tomography Int. J. Cardiol. 167 5 2013 e123 e126
23. T. Naganuma, S. Basavarajaiah, A. Latib, C. Costopoulos, and A. Colombo Use of BVS in a chronic total occlusion with bifurcation lesion Int. J. Cardiol. 167 2013 e129 e131
24. T. Gori, G. Guagliumi, and T. Münzel Absorb bioresorbable scaffold implantation for the treatment of an ostial chronic total occlusion Int. J. Cardiol. 172 2014 e377 e378
25. A.S. Sharp, A. Latib, A. Ielasi, C. Larosa, C. Godino, M. Saolini, V. Magni, R.T. Gerber, M. Montorfano, M. Carlino, I. Michev, A. Chieffo, and A. Colombo Long-term follow-up on a large cohort of "full-metal jacket" percutaneous coronary intervention procedures Circ. Cardiovasc. Interv. 2 2009 416 422
26. J. Iqbal, W. Sumaya, V. Tatman, Y. Parviz, A.C. Morton, E.D. Grech, S. Campbell, R.F. Storey, and J. Gunn Incidence and predictors of stent thrombosis: a single-centre study of 5,833 consecutive patients undergoing coronary artery stenting EuroIntervention 9 2013 62 69
27. A.R. Galassi, S.D. Tomasello, N. Reifart, G.S. Werner, G. Sianos, H. Bonnier, H. Sievert, S. Ehladad, A. Bufe, J. Shofer, A. Gershlick, D. Hildick-Smith, J. Escaned, A. Erglis, I. Sheiban, L. Thuesen, A. Serra, E. Christiansen, A. Buettner, L. Costanzo, G. Barrano, and C. Di Mario In-hospital outcomes of percutaneous coronary intervention in patients with chronic total occlusion: insights from the ERCTO (European Registry of Chronic Total Occlusion) registry EuroIntervention 7 2011 472 479
28. G.S. Werner, M. Hochadel, U. Zeymer, S. Kerber, B. Schumacher, E. Grube, K.E. Hauptmann, M. Brueck, R. Zahn, and J. Senges Contemporary success and complication rates of percutaneous coronary intervention for chronic total coronary occlusions: results from the ALKK quality control registry of 2006 EuroIntervention 6 2010 361 366